Natixis Advisors’s Guardant Health GH Stock Holding History

Natixis Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.19M	Buy	27,937 +12,277	+78%	+$1.34M	﹤0.01%	974
2026 Q1	$1.45M	Buy	+15,660	New	+$1.57M	﹤0.01%	1228
2025 Q4	–	Sell	-26,878	Closed	-$1.68M	–	1648
2025 Q3	$1.68M	Sell	26,878 -384	-1%	-$20.9K	﹤0.01%	1152
2025 Q2	$1.42M	Buy	27,262 +4,164	+18%	+$186K	﹤0.01%	1189
2025 Q1	$984K	Buy	+23,098	New	+$997K	﹤0.01%	1274
2020 Q4	–	Sell	-87,712	Closed	-$9.8M	–	1227
2020 Q3	$9.8M	Buy	87,712 +1,525	+2%	+$140K	0.06%	324
2020 Q2	$6.99M	Buy	86,187 +12,719	+17%	+$1.02M	0.05%	404
2020 Q1	$5.11M	Buy	+73,468	New	+$5.64M	0.04%	448

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Natixis Advisors's GH Position: Q2 2026 in Review

Natixis Advisors increased its Guardant Health (GH) stake by 78% in Q2 2026, buying an estimated $1.34M and bringing the position to 27,937 shares worth $4.19M. The position accounts for ﹤0.01% of the portfolio, ranked #974.

Natixis Advisors first reported a position in GH in Q1 2020 and has held it in 8 quarters since. The position peaked at $9.8M in Q3 2020. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Natixis Advisors held 27,937 shares of Guardant Health worth $4.19M as of Q2 2026.
Natixis Advisors bought 12,277 Guardant Health shares in Q2 2026, an estimated $1.34M.
Guardant Health made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #974 holding.
Natixis Advisors first reported a position in Guardant Health in Q1 2020 and has held it in 8 quarters since.
Natixis Advisors's Guardant Health position peaked at $9.8M in Q3 2020.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.